You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

palbociclib

( PAL boe SYE klib )
Funding:
Exceptional Access Program
  • For the treatment of post-menopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative unresectable locally advanced breast cancer or metastatic breast cancer, according to clinical criteria
Other Name(s): Ibrance™
Appearance: capsule in various strengths

Patient Info Sheet

Aug 2018

What it is used for

  • For treating breast cancer that has spread to other parts of the body, in combination with drugs that reduce estrogen levels or effects (aromatase inhibitors or fulvestrant).


You might also be interested in